Craig Bijou
Stock Analyst at B of A Securities
(3.75)
# 690
Out of 5,154 analysts
70
Total ratings
58.97%
Success rate
51.37%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Downgrades: Underperform | $38 → $20 | $24.22 | -17.42% | 6 | Feb 26, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $82 → $92 | $74.27 | +23.87% | 3 | Jan 5, 2026 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $87.10 | +4.48% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $7.69 | +17.04% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $113.31 | +23.55% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $17.06 | -0.35% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $9.73 | +84.99% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $84.03 | +72.56% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $72.66 | +41.76% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $64.13 | +32.54% | 1 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $76.55 | +24.10% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $13.83 | +160.30% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $9.98 | +350.90% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $11.38 | +954.48% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $6.85 | +337.96% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8.5 → $6.5 | $12.34 | -47.33% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $12.62 | +232.81% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $490.16 | -53.08% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $364.56 | -36.91% | 4 | Jul 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $10.05 | - | 3 | Dec 4, 2017 |
PROCEPT BioRobotics
Feb 26, 2026
Downgrades: Underperform
Price Target: $38 → $20
Current: $24.22
Upside: -17.42%
GE HealthCare Technologies
Jan 5, 2026
Maintains: Neutral
Price Target: $82 → $92
Current: $74.27
Upside: +23.87%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $87.10
Upside: +4.48%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $7.69
Upside: +17.04%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $113.31
Upside: +23.55%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $17.06
Upside: -0.35%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $9.73
Upside: +84.99%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $84.03
Upside: +72.56%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $72.66
Upside: +41.76%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $64.13
Upside: +32.54%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $76.55
Upside: +24.10%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $13.83
Upside: +160.30%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $9.98
Upside: +350.90%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $11.38
Upside: +954.48%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $6.85
Upside: +337.96%
Mar 24, 2020
Reiterates: Overweight
Price Target: $8.5 → $6.5
Current: $12.34
Upside: -47.33%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $12.62
Upside: +232.81%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $490.16
Upside: -53.08%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $364.56
Upside: -36.91%
Dec 4, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $10.05
Upside: -